antibiotic g 418 has been researched along with Adult Spinal Muscular Atrophy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| DiDonato, CJ; Heier, CR | 2 |
2 other study(ies) available for antibiotic g 418 and Adult Spinal Muscular Atrophy
| Article | Year |
|---|---|
ECG in neonate mice with spinal muscular atrophy allows assessment of drug efficacy.
Topics: Animals; Animals, Newborn; Biomarkers; Bradycardia; Disease Models, Animal; Drug Evaluation, Preclinical; Electrocardiography; Gentamicins; Heart; Heart Block; Heart Conduction System; Mice; Motor Activity; Muscular Atrophy, Spinal; Random Allocation; Toxicity Tests | 2015 |
Translational readthrough by the aminoglycoside geneticin (G418) modulates SMN stability in vitro and improves motor function in SMA mice in vivo.
Topics: Aminoglycosides; Animals; Base Sequence; Cell Line; Codon, Terminator; Exons; Fibroblasts; Gentamicins; Humans; Mice; Molecular Sequence Data; Motor Activity; Muscular Atrophy, Spinal; Protein Biosynthesis; Protein Stability; Survival of Motor Neuron 1 Protein | 2009 |